Effect of gamma radiation on resting B lymphocytes. I. Oxygen-dependent damage to the plasma membrane results in increased permeability and cell enlargement.
Although the susceptibility of resting B lymphocytes to radiation-induced interphase death is well known, the mechanism by which this occurs is not understood. In this report, we use three measures of plasma membrane integrity (increase in cell volume, uptake of trypan blue, and release of 51Cr) to assess the effect of radiation on the resting B cell plasma membrane. The delivery of 500 to 1000 rad caused the majority of resting B cells to enlarge slightly, whereas 3000 rad caused virtually all of the cells to approximately double in size within 3 to 4 hr. Measurement of the release of 51Cr from resting B cells revealed a similar relationship between the dose of radiation and the loss of radioactive label. Trypan blue exclusion was also found to diminish as a function of radiation dose. An analysis of a variety of lymphoid cells suggested that sensitivity to the membrane damaging effects of gamma radiation was in the order of resting B cells greater than resting T cells greater than a long-term L3T4+ T cell clone greater than a B cell lymphoma. LPS-induced B cell blasts treated with 3000 rad were equivalent to 1000 rad-treated resting B cells. The effects of the gamma radiation could be ameliorated by excluding oxygen (a diradical molecule that can potentially enhance the generation and propagation of highly reactive free radicals) at the time of irradiation, or by adding the free radical scavenging agent cysteamine. These data are compatible with the hypothesis that gamma radiation results in damage to the plasma membrane of resting lymphocytes via the generation of highly reactive free radical species. This damage is reflected in a rapid increase in plasma membrane permeability and swelling of the cells, and may play a major role in causing interphase death.
D000818:Animals; D001402:B-Lymphocytes / Q000166:cytology / Q000187:drug effects / Q000528:radiation effects*; D002460:Cell Line; D002462:Cell Membrane / Q000528:radiation effects; D002463:Cell Membrane Permeability / Q000187:drug effects / Q000528:radiation effects; D002478:Cells, Cultured; D002945:Cisplatin / Q000494:pharmacology; D003543:Cysteamine / Q000494:pharmacology; D004307:Dose-Response Relationship, Radiation; D005609:Free Radicals; D005720:Gamma Rays; D000860:Hypoxia; D007399:Interphase; D051379:Mice; D016685:Mitomycin; D008937:Mitomycins / Q000494:pharmacology; D010100:Oxygen / Q000633:toxicity; D011837:Radiation-Protective Agents / Q000494:pharmacology; D013601:T-Lymphocytes / Q000528:radiation effects
D005609:Free Radicals; D008937:Mitomycins; D011837:Radiation-Protective Agents; D016685:Mitomycin; D003543:Cysteamine; D002945:Cisplatin; D010100:Oxygen